Clinical Trial Details
— Status: Completed
Administrative data
| NCT number |
NCT03645694 |
| Other study ID # |
1502S63961 |
| Secondary ID |
R44AG041667 |
| Status |
Completed |
| Phase |
Phase 2
|
| First received |
|
| Last updated |
|
| Start date |
November 1, 2016 |
| Est. completion date |
August 15, 2018 |
Study information
| Verified date |
April 2022 |
| Source |
University of Minnesota |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Interventional
|
Clinical Trial Summary
The goal of this study is to determine the acceptability, utility, and preliminary
effectiveness of a facial recognition technology for persons with memory concerns and their
family care partners.
Description:
This project develops a novel social support aid (SSA) to allow persons with memory concerns
(PWMCs) to more fully engage in their social network and enhance their quality of life. The
SSA will assist people in an early stage of dementia, e.g., Alzheimer's disease or related
dementia, who desire social interaction, but struggle to remember names and relationships. It
provides memory cuing by displaying the names and relationships of the people with whom PWMCs
are engaged. The investigators anticipate that the SSA will offer robust support for care
partners and PWMCs in various communities. The SSA is not intended to replace caregiver aids,
but rather augment them to further improve quality of life. Millions of Americans have
dementia, the loss of mental functions, e.g., thinking, memory, and reasoning, which
interferes with their daily functioning. While some cases of dementia are caused by medical
conditions that can be treated, most cannot be reversed. Hence, the focus switches from
treatment to palliative care, i.e., developing a plan to make life easier and more
comfortable for individuals with dementia and their caregivers. Assistive technologies to
enhance living with dementia, let alone studies that evaluate their efficacy, are
underdeveloped. The proposed project aims to begin filling this scientific and clinical gap
by developing a social support aid and formally evaluating its utility via a sufficiently
powered randomized controlled trial.
This phase II Small Business Innovation Research project will continue work started in phase
I and complete a product. The aim of this human subjects research protocol is to evaluate
whether the SSA exerts positive benefits for PWMCs' social connections, communication, and
quality of life via an embedded experimental mixed methods design that combines the
collection and analysis of qualitative data within a traditional randomized controlled trial
(RCT) design. The investigators hypothesize that the proposed SSA will exert positive
benefits on the social connections, communication, and quality of life of people in early
stage dementia.